Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian virus 40 | 8 | 2009 | 190 | 0.600 |
Why?
|
| Pneumonia, Viral | 4 | 2021 | 351 | 0.450 |
Why?
|
| Intensive Care Units | 4 | 2021 | 526 | 0.400 |
Why?
|
| Tumor Virus Infections | 6 | 2004 | 131 | 0.390 |
Why?
|
| Polyomavirus Infections | 5 | 2009 | 87 | 0.380 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 339 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2012 | 499 | 0.260 |
Why?
|
| Critical Care | 3 | 2022 | 686 | 0.250 |
Why?
|
| Pandemics | 6 | 2022 | 1118 | 0.220 |
Why?
|
| DNA, Viral | 6 | 2009 | 448 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 682 | 0.220 |
Why?
|
| Medical Laboratory Personnel | 1 | 2004 | 14 | 0.210 |
Why?
|
| Laboratories, Hospital | 1 | 2004 | 24 | 0.210 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2004 | 84 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1295 | 0.200 |
Why?
|
| Quality of Life | 1 | 2012 | 2082 | 0.180 |
Why?
|
| Meningioma | 1 | 2004 | 151 | 0.180 |
Why?
|
| Nurse Practitioners | 1 | 2022 | 50 | 0.170 |
Why?
|
| Transportation of Patients | 1 | 2021 | 51 | 0.160 |
Why?
|
| Physician Assistants | 1 | 2022 | 81 | 0.160 |
Why?
|
| Betacoronavirus | 2 | 2020 | 275 | 0.160 |
Why?
|
| Vaping | 1 | 2020 | 31 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 69 | 0.150 |
Why?
|
| Cough | 1 | 2020 | 97 | 0.150 |
Why?
|
| Mesothelioma | 2 | 2003 | 97 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2021 | 250 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 333 | 0.140 |
Why?
|
| Pleural Neoplasms | 1 | 2000 | 84 | 0.140 |
Why?
|
| Leukemia | 1 | 2021 | 387 | 0.130 |
Why?
|
| Fever | 1 | 2020 | 312 | 0.130 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2021 | 259 | 0.130 |
Why?
|
| Disease Management | 1 | 2021 | 558 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 71 | 0.120 |
Why?
|
| Sepsis | 1 | 2020 | 493 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 1306 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 1447 | 0.110 |
Why?
|
| Critical Illness | 3 | 2022 | 630 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 689 | 0.080 |
Why?
|
| Humans | 21 | 2022 | 131163 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2000 | 1545 | 0.080 |
Why?
|
| Texas | 3 | 2021 | 3686 | 0.070 |
Why?
|
| Pediatrics | 1 | 2017 | 1252 | 0.060 |
Why?
|
| Child | 8 | 2022 | 26341 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2009 | 262 | 0.060 |
Why?
|
| Male | 9 | 2021 | 64957 | 0.060 |
Why?
|
| Infant | 5 | 2021 | 13352 | 0.060 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 808 | 0.060 |
Why?
|
| Polyomavirus | 2 | 2002 | 31 | 0.050 |
Why?
|
| Papillomavirus Infections | 2 | 1999 | 394 | 0.050 |
Why?
|
| Poliovirus Vaccines | 1 | 2003 | 13 | 0.050 |
Why?
|
| Drug Contamination | 1 | 2003 | 35 | 0.050 |
Why?
|
| Gadolinium | 1 | 2004 | 110 | 0.050 |
Why?
|
| Adolescent | 5 | 2021 | 20987 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2000 | 252 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2022 | 66 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 10103 | 0.050 |
Why?
|
| Female | 7 | 2021 | 70963 | 0.040 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 558 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2021 | 15110 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 2021 | 29 | 0.040 |
Why?
|
| Ventilation | 1 | 2021 | 7 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 21 | 0.040 |
Why?
|
| Hospitalization | 2 | 2020 | 1950 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 776 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 47 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 1692 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 120 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2021 | 48 | 0.040 |
Why?
|
| Alanine | 1 | 2021 | 160 | 0.040 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 32 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17753 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 269 | 0.040 |
Why?
|
| Shock | 1 | 2020 | 100 | 0.040 |
Why?
|
| Base Sequence | 2 | 2000 | 2730 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 158 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 582 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2000 | 124 | 0.030 |
Why?
|
| Monkey Diseases | 1 | 1998 | 17 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 3464 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 526 | 0.030 |
Why?
|
| Neoplasms | 2 | 2003 | 3016 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2000 | 357 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 373 | 0.030 |
Why?
|
| Survivors | 1 | 2020 | 344 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8635 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 1998 | 146 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 721 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 645 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 501 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2021 | 810 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 1998 | 504 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12936 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 11074 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3748 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2021 | 605 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 1998 | 315 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1882 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 5063 | 0.020 |
Why?
|
| Antibodies, Viral | 3 | 2009 | 1176 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 3763 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 362 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 258 | 0.020 |
Why?
|
| United States | 1 | 2022 | 12072 | 0.020 |
Why?
|
| Placenta | 1 | 2009 | 504 | 0.010 |
Why?
|
| Denmark | 1 | 2003 | 28 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 203 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 31282 | 0.010 |
Why?
|
| Brain | 2 | 2009 | 3175 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2003 | 163 | 0.010 |
Why?
|
| Middle Aged | 1 | 2000 | 28601 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 73 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 475 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1999 | 118 | 0.010 |
Why?
|
| Capsid | 1 | 1998 | 93 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 1998 | 132 | 0.010 |
Why?
|
| Leukocytes | 1 | 1998 | 205 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 7512 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3360 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1999 | 421 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2395 | 0.010 |
Why?
|
| Animals | 2 | 2009 | 33912 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1998 | 1559 | 0.010 |
Why?
|